Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer

Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer

Abstract Relevance. Circulating tumor cells (CTC) are a biological marker of new generation, which provides additional information on the biological features and prognosis of the disease. The possibility of using CTC for early evaluation of the effectiveness of drug treatment of breast cancer (BC),...

Full description

Bibliographic Details
Main Authors:	Yu N Nenakhova, V K Lyadov, I V Poddubnaya
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2017-09-01
Series:	Современная онкология
Subjects:	рак молочной железы неоадъювантное лекарственное лечение циркулирующие опухолевые клетки изоляция клеток по размеру
Online Access:	https://modernonco.orscience.ru/1815-1434/article/viewFile/27160/pdf

Similar Items

Circulating tumor cells in breast cancer: clinical and molecular parallels
by: A. V. Zyuzyukina, et al.
Published: (2021-09-01)

Signs of apoptosis in circulating tumor cell subpopulations with phenotypes associated with stemness and epithelial-mesenchymal transition in breast carcinoma
by: V. M. Perelmuter, et al.
Published: (2022-12-01)

CXCR4 EXPRESSION IN DIFFERENT SUBSETS OF CTCs AND SINGLE (DETACHED) BREAST CANCER CELLS
by: O. E. Savelieva, et al.
Published: (2018-09-01)

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01)

Overall survival in colon cancer patients with different levels of circulating tumor cells and feasibility of enhancing its prognostic value
by: O. I. Kit, et al.
Published: (2022-09-01)

CELL MEDIATED IMMUNITY IN PATIENTS WITH STAGE II–IV COLORECTAL CANCER WITH OR WITHOUT CIRCULATING TUMOR CELLS
by: E. Y. Zlatnik, et al.
Published: (2020-09-01)

THE PRESENCE OF VARIOUS POPULATIONS OF CIRCULATING TUMOR CELLS IN THE BLOOD OF BREAST CANCER PATIENTS BEFORE TREATMENT: ASSOCIATION WITH FIVE-YEAR METASTASIS-FREE SURVIVAL
by: E. V. Kaigorodova, et al.
Published: (2020-12-01)

CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01)

Drug treatment for metastatic breast cancer
by: E. V. Artamonova
Published: (2014-08-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Current standards for primary breast cancer treatment (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

APPLICATION OF HEMOFILTERCYTOLOGICAL TESTS FOR ASSIGNING ADJUVANT POLYCHEMOTHERAPHY TO CANCER PATIENTS AND EVALUATING ITS EFFICACY
by: Георгий Цыренович Дамбаев, et al.
Published: (2022-03-01)

Treatment of patients with bone marrow metastases: the present state of the problem
by: S. P. Kozlovskaya, et al.
Published: (2016-06-01)

Strategy of post-neoadjuvant treatment of patients with residual breast cancer
by: V. V. Semiglazov, et al.
Published: (2020-06-01)

Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM)
by: A. A. Bozhok, et al.
Published: (2017-02-01)

EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01)

The association between detection the presence of KRAS mutations in tumors and circulating tumor cells from patients with colorectal cancer
by: O. I. Kit, et al.
Published: (2016-02-01)

Current aspects of comprehensive treatmentfor advanced breast cancer (literature review and analysis of original material)
by: D. D. Pak, et al.
Published: (2016-02-01)

Cancer stem cells are new vistas for predicting the course of breast cancer
by: E. A. Maslyukova, et al.
Published: (2015-09-01)

The specific features of T cell immunity in breast cancer
by: L. V. Skotarenko, et al.
Published: (2014-08-01)

NEW DIAGNOSTIC POSSIBILITIES AND TRADITIONAL POSITIONS IN MODERN ONCOLOGY
by: Анатолий Агванович Чимитов, et al.
Published: (2021-09-01)

Treatment for Paget’s disease: surgical approaches
by: E. Yu. Fetisova, et al.
Published: (2015-07-01)

Twenty-year experience of examining biopsies of signal lymph nodes in breast cancer
by: V. F. Semiglazov, et al.
Published: (2020-06-01)

Role of liquid biopsy in the detection and monitoring of cervical cancer
by: E. V. Kayukova
Published: (2019-04-01)

THE IMPORTANCE OF CIRCULATING TUMOR DNA IN THE ASSESSMENT OF METASTATIC COLORECTAL CANCER TREATMENT EFFECTIVNE
by: M. I. Sluzhev, et al.
Published: (2021-10-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

POSSIBILITIES OF DIAGNOSIS OF RADIATION INJURIES AND REHABILITATION OF PATIENTS AFTER COMBINED TREATMENT OF MALIGNANT TUMORS OF THE BREAST
by: A. V. Kondakov, et al.
Published: (2016-03-01)

The clinical significance of breast cancer stem cells (review of literature)
by: I. B. Schepotin, et al.
Published: (2014-11-01)

Current standards for the treatment of metastatic breast cancer (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
by: - -
Published: (2014-06-01)

RELATIONSHIP BETWEEN THE BLOOD LEVELS OF INFLAMMATORY CYTOKINES AND THE NUMBER OF CIRCULATING TUMOR CELLS WITH RESPONSE TO STANDARD CHEMOTHERAPY IN PATIENTS WITH OVARIAN CANCER
by: S. O. Gening, et al.
Published: (2021-03-01)

Neuroendocrine tumors of the vagina
by: S. O. Nikogosyan, et al.
Published: (2015-09-01)

Reconstructive plastic operations in the treatment of patients with breast cancer
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
by: E. V. Kaigorodova, et al.
Published: (2020-04-01)

Lipofilling as a method of reconstructive treatment of breast cancer patients (а review of literature)
by: R. V. Lyubota, et al.
Published: (2015-01-01)

Оrgan-preserving surgery for breast cancer
by: D. D. Pak, et al.
Published: (2014-07-01)

EXPERIENCE IN TREATING PATIENTS WITH LOCALLY ADVANCED BREAST CANCER
by: G. A. Khakimov, et al.
Published: (2014-09-01)

Rationale for repeat breast-conserving surgery after in-breast recurrence of breast cancer
by: V. A. Uimanov, et al.
Published: (2014-07-01)